CryoPort (NASDAQ:CYRX) issued its quarterly earnings data on Thursday. The consumer goods maker reported ($0.07) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.08) by $0.01, Briefing.com reports. The firm had revenue of $5.30 million during the quarter, compared to analysts’ expectations of $5.06 million. CryoPort had a negative net margin of 62.80% and a negative return on equity of 45.60%. CryoPort’s revenue for the quarter was up 76.7% on a year-over-year basis. During the same period in the prior year, the company posted $0.08 earnings per share.
CYRX stock traded down $0.19 during mid-day trading on Friday, reaching $11.37. 180,626 shares of the stock traded hands, compared to its average volume of 217,421. CryoPort has a 52 week low of $6.02 and a 52 week high of $16.88. The stock has a market capitalization of $329.71 million, a price-to-earnings ratio of -33.44 and a beta of 1.42.
In other CryoPort news, CEO Richard J. Berman sold 20,000 shares of the company’s stock in a transaction dated Wednesday, August 15th. The shares were sold at an average price of $12.81, for a total transaction of $256,200.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Richard J. Berman sold 10,000 shares of the company’s stock in a transaction dated Thursday, September 6th. The shares were sold at an average price of $14.00, for a total transaction of $140,000.00. The disclosure for this sale can be found here. 9.60% of the stock is owned by corporate insiders.
A number of hedge funds have recently added to or reduced their stakes in CYRX. Strs Ohio bought a new stake in CryoPort during the second quarter valued at about $115,000. Metropolitan Life Insurance Co. NY bought a new stake in CryoPort during the second quarter valued at about $136,000. FNY Investment Advisers LLC bought a new stake in CryoPort during the third quarter valued at about $147,000. Greenwood Capital Associates LLC bought a new stake in CryoPort during the second quarter valued at about $163,000. Finally, MetLife Investment Advisors LLC bought a new stake in CryoPort during the second quarter valued at about $192,000. Institutional investors own 48.25% of the company’s stock.
A number of brokerages recently issued reports on CYRX. B. Riley began coverage on shares of CryoPort in a report on Wednesday, October 10th. They issued a “buy” rating and a $22.00 price objective for the company. Cowen upped their price objective on shares of CryoPort from $11.00 to $16.00 and gave the stock an “outperform” rating in a report on Monday, August 13th. Finally, BidaskClub cut shares of CryoPort from a “buy” rating to a “hold” rating in a report on Wednesday, August 15th. One analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. CryoPort has a consensus rating of “Buy” and an average price target of $19.75.
TRADEMARK VIOLATION NOTICE: “CryoPort (CYRX) Announces Earnings Results, Beats Expectations By $0.01 EPS” was posted by Equities Focus and is the sole property of of Equities Focus. If you are reading this news story on another domain, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The original version of this news story can be read at https://www.equitiesfocus.com/2018/11/10/cryoport-cyrx-announces-earnings-results-beats-expectations-by-0-01-eps.html.
CryoPort Company Profile
Cryoport, Inc provides cryogenic logistics solutions to the life sciences industry in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, a dry vapor cryogenic shipper that use liquid nitrogen contained inside a vacuum insulated vessel, which serves as a refrigerant to provide stable storage temperatures.
Read More: Should you buy a closed-end mutual fund?
Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.